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Abstract 
We performed immunocytochemical studies to analyze the inflammatory infiltrate and major 
histocompatibility complex class II (Ia) antigen expression in the spinal cord of Lewis rats with acute 
experimental allergic encephalomyelitis (EAE) induced by inoculation with myelin basic protein and 
adjuvants. Using antibodies to lymphocyte markers and other monoclonal antibodies we found that 
during clinical episodes the inflammatory infiltrate was chiefly composed of T lymphocytes and 
macrophages. The majority of cells in the inflammatory infiltrate were stained by the W3/25 antibody 
to CD4 and a proportion was stained by OX22 which labels the high molecular weight form of the 
leucocyte common antigen (CD45RC). CDB+ T cells were sparse and B cells were not detected. There 
was minimal staining with the OX39 antibody to the interleukin-2 receptor. Presumptive microglia, 
identified by their dendritic morphology, expressed Ia antigen during the clinical episodes and after 
recovery. The prominence of Ia antigen expression after recovery could indicate that this la expression 
was associated with downregulation of the encephalitogenic immune response. We also performed 
flow cytometry studies on cells extracted from the spinal cord of rats before and during attacks of EAE. 
With flow cytometry, we found that in established disease a mean of 83(SD, 23)% of CD2+ cells were 
CD4+, and a mean of 27(SD, 12)% of CD2+ cells were CD45RC+. In rats sampled on the first day of 
signs, a mean of 43(SD, 22)% of CD2+ cells were CD45RC+. In the cells extracted from the spinal 
cord of rats with established disease a mean of 47(SD, 32)% of macrophages were CD45RC+. Our 
study has combined an immunocytochemical assessment of tissue sections with quantitative flow 
cytometry assessment of cells extracted from the spinal cord of rats with acute EAE. We have shown 
that the majority of T lymphocytes in the spinal cord are CD45RC−. We have also found prominent Ia 
expression on dendritic cells in acute EAE and after clinical recovery. 
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Introduction 
 
Experimental allergic encephalomyelitis (EAE) is an autoimmune demyelinating disease 
induced by inoculation of susceptible animals with central nervous system myelin (CNS) 
antigens and adjuvants. The pathology of EAE is dominated by inflammation and 
demyelination in the central and peripheral nervous systems (Raine 1984; Pender 1987). 
Immunocytochemical studies of different models of EAE have shown that the inflammatory 
infiltrate consists of macrophages and T lymphocytes. EAE induced by inoculation with 
myelin basic protein (MBP-EAE) is useful in the study of the pathogenesis of the EAE 
because the target antigen is well characterized. In the Lewis rat two previous 
immunocytochemical studies of actively induced MBPEAE (Hickey et al. 1983, 1985) have 
shown that the predominant inflammatory cells are CD4+ and express the major 
histocompatibility complex class II (Ia) antigen. In the rat, the monoclonal antibody OX22 
labels an epitope found in exon 5 of CD45RC, a high molecular weight form of the leucocyte 
common antigen which is expressed on B cells and CD4 + and CD8 + lymphocytes (Spickett 
et al. 1983; Barclay et al. 1987; Thomas and Lefrancois 1988; Powrie and Mason 1990, 
1991). OX22 labelling divides CD4+ T lymphocytes into two populations (Spickett et al. 
 1983; Powrie and Mason 1990; 1991). CD45RC+CD4+ T cells are the more potent 
producers of interleukin-2 (IL-2) and interferon-y (IFN-γ) (Mason and Powrie 1990), 
whereas the CD45RC-CD4+ subpopulation provides B cell help and produces 
interleukin-4 (Arthur and Mason 1986; McKnight et al. 1991). We have used OX22 and 
other monoclonal antibodies to study further the inflammatory infiltrate and Ia antigen 
expression in MBP-EAE in the Lewis rat, using immunocytochemistry to assess the 
location of cells in sections of spinal cord, and flow cytometry to study cells extracted 
from the whole spinal cord. 
 
Materials and methods 
 
Animals 
Lewis rats (JC strain) aged 9-12 weeks were obtained from the animal breeding facility 
of The University of Queensland. 
 
Myelin basic protein (MBP) 
MBP was prepared from guinea-pig spinal cords, from which the roots had been 
removed, by the method of Deibler et al. (1972). The purity of the preparation was 
established by SDS-polyacrylamide gel electrophoresis. 
 
Induction of EAE 
MBP in 0.9% saline was emulsified in an equal volume of incomplete Freund's adjuvant 
containing 4 mg/ml Mycobacterium butyricum. Rats were inoculated with 0.1 ml 
emulsion in each hindfoot. The total dose of MBP was 50 µg rat. 
 
Clinical assessment 
Animals were examined daily from day 7 after inoculation. Weakness of the tail and 
limbs was assessed and graded on a scale of 0 (no weakness) to 4 (complete paralysis) 
for each region as previously described (Pender 1986). A total disability score was 
obtained by adding the scores for the three regions. 
 
Controls 
Uninoculated normal animals were used as controls. 
 
Preparation of tissue for immunocytochemistry 
In our initial studies, rats were perfused with Nakane's solution (McLean and Nakane 
1974). These animals were dissected and, after further immersion in fixative, specimens 
were immersed overnight in sucrose and frozen for cryosectioning. In later experiments, 
rats were perfused with ice-cold saline, the spinal cords were removed rapidly by 
insufflation, the tissue was immediately frozen, and frozen sections of unfixed tissue 
were prepared. These sections were then fixed in acetone/ ethanol for 5-10 min and used 
immediately or stored at - 20°C for use up to 6 weeks later. 
 
Antibodies 
The following monoclonal antibodies were obtained from Serotec: R73 (a//3 T cell 
receptor), OX34 and OX54 (CD2), OX52 (T cells), OX19 (CD5), OX39 (CD25; IL-2 
receptor [IL-2R]), OX22 (CD45RC), OX8 (CD8), OX33 (leukocyte common antigen on 
B cells), OX6 (Ia antigen), OX42 (type 3 complement receptor on macrophages and 
microglia) and W3/25 (CD4 on T cells and macrophages). Polyclonal antibody to glial 
fibrillary acidic protein (GFAP) was obtained from Dako and to MBP was obtained 
from advanced immunocytochemicals. 
 
Isolation of inflammatory cells from spinal cords 
Rats with clinical signs of MBP-EAE were perfused via the left ventricle with cold, 
sterile, isotonic saline supplemented with 10 IU/ml sodium heparin. Spinal cords were 
removed by insufflation, weighed, passed through a 200-mesh stainless steel sieve and 
suspended in Hank's balanced salt solution (Sigma). Inflammatory cells were isolated 
 by the method of Cohen et al. (1987). A two-step discontinuous Percoll (Pharmacia) 
gradient was prepared by adding 10 ml isotonic Percoll to the spinal cord suspension 
and underlaying this 1.04 g/ml layer with 5 ml 1.08 g/ml Percoll solution. After 
centrifugation at 1500 x g for 30 min at 4°C, inflammatory cells were collected from the 
1.04-1.08 interface. 
 
Immunostaining 
In preliminary experiments, 5-µm sections were incubated with mouse monoclonal 
antibodies and then with biotinylated anti-mouse immunoglobulin and horseradish 
peroxidase-conjugated avidin according to the methods of Lassmann et al. (1986b). In 
later experiments, sections were incubated with primary mouse monoclonal antibodies 
and then with peroxidase-conjugated rabbit anti-mouse immunoglobulin (Dakopatts). In 
all cases, the sections were exposed to normal rabbit serum to block non-specific 
binding, and washed care-fully with phosphate-buffered saline between incubations. 
The sections were exposed to diaminobenzidine for 10-15 min and, if required, were 
counterstained with Mayer's haematoxylin. Sections were assessed on a Zeiss Axiophot 
microscope, and cells were regarded as positively stained if the cell outline was dark 
brown. In all cases, sections without primary antibody were used as controls. Indirect 
peroxidase staining of cells extracted from the spinal cord was performed on cells in 
suspension. After staining the cells were air-dried onto a slide for microscopic 
examination. 
 
Immunofluorescent-labelling of leukocyte surface markers and flow cytometry 
Aliquots of 100 of cell suspension (2 x 106 to 10'/ml) were incubated with 100 µl (5 µg) 
monoclonal mouse anti-rat leukocyte primary antibody (Serotec) for 30 min at 4°C. 
Cells were washed 2-3 times in 1 ml cold phosphate-buffered saline (PBS), 1% FCS, 
0.1% sodium azide at 600 X g for 5 min at 4°C. The secondary antibody was a rat IgG-
adsorbed affinity purified F(ab')2 rabbit anti-mouse IgG-R-Phycoerythrin conjugate 
(Serotec). Secondary antibody was diluted 1 in 20 in PBS, with or without 10% normal 
JC Lewis rats serum. 100 Al aliquots of cell suspensions were incubated with 100 
secondary antibody solution for 30-60 min at 4°C in the dark. Cells were again washed 
as described above. For double-labelling experiments fluorescein-conjugated 
monoclonal antibodies (5 µg protein) (Serotec) was incubated with cells in an incu-
bation volume of 200 µl for 30 min at 4°C in the dark. Cells were washed as above and 
resuspended in 0.3 ml PBS, 1% FCS, 0.1% sodium azide and stored on ice in the dark 
prior to flow cytometric analysis. Control cell samples were incubated with secondary 
antibody only. The number of dead cells in each sample was estimated by incubation 
with 50 µg/ml propidium iodide (Sigma) for 5 min on ice before analysis. Blocking 
stages with incubation with 10% normal rabbit serum (Dako) for 10 min at 4°C prior to 
incubation with the first mouse monoclonal antibody, and either 10 µg normal 
Quackenbush mouse serum for 10 min before the addition of fluroescein-conjugated 
monoclonal antibodies, were included in the labelling procedure for some experiments. 
 
Flow cytometry 
Immunofluorescence analysis was performed using a FACScan flow cytometer and 
LYSYS software both supplied by Becton Dickinson. Fluorescein isothiocyanate 
(FITC), R-phycoerythrin (PE) and propidium iodide (PI) were excited using the 488 
nm line of an argon laser and emission was detected at 530 nm (FITC) and 585 nm 
(PE/PI). Compensation for the detection of unwanted fluorescent signals, due to the 
overlap of emission spectra of the fluorescent dyes, was set when two- and three-colour 
fluorescence was used. Fluorescence data were collected using logarithmic 
amplification on 10 000 cells (both viable and non-viable) excluding events below a 
forward light scatter threshold of 140. Percentages of positively-labelled cell 
subpopulations were calculated by subtracting the equivalent control values in all 
cases. 
 Results 
 
Clinical observations 
Rats developed clinical signs of EAE (weakness of the tail, hindlimbs and sometimes 
forelimbs) on days 11-14 after inoculation. Neurologic signs were present for 3-6 days, 
after which time the animals regained normal strength. 
 
 
 
Fig. 1. Sections from the spinal cord of rats with neurological signs of MBP-EAE. Sections are stained with 
mouse monoclonal antibodies to cell surface antigens using the indirect peroxidase technique. A: section 
stained with OX34. There is a T cell infiltrate in the spinal cord. Bar = 25 µm. B: section stained with R73. 
There is a T cell infiltrate in the subpial region and in the white matter. Bar = 100 µm. C: section stained 
with OX22. There are many positively stained cells. Bar = 25 µm. D: section stained with OX42 which 
labels infiltrating macrophages and resident microglia. Many positively stained round cells and dendritic 
cells are present. Bar = 50 µm. 
 
Preliminary trial of fixation and staining methods 
Sections were prepared of tissues from animals perfused with Nakane's solution, 
 or from animals perfused with ice-cold saline. Tissue fixed with Nakane's solution 
gave inconsistent immunostaining results with high background staining and little 
staining with anti-lymphocyte antibodies. Tissue from the animals per-fused with ice-
cold saline gave consistent immunostaining and low background staining, and these 
sections were used for the remainder of the study. More consistent results were 
obtained with the indirect peroxidase technique than with the avidin-biotin 
technique. The results of immunostaining of sections from rats with EAE were 
therefore obtained using indirect peroxidase staining of frozen sections from 
animals perfused with ice-cold saline.   
 
Testing of different monoclonal antibodies 
 
Lymph node. Monoclonal antibodies were tested on frozen sections of popliteal 
lymph nodes from a normal animal and an animal with EAE. All antibodies gave good 
staining. OX39, which labels the IL-2R on activated lymphocytes, was positive only on 
sections of the popliteal lymph node draining the inoculation site of the animal with 
EAE. 
Nervous system. We compared different antibodies on spinal cord sections from EAE 
rats. These sections were shown by staining with haematoxylin and eosin to have a 
significant inflammatory infiltrate. The anti-lymphocyte antibodies R73 and OX34 
were most effective and gave consistently good staining. OX52 and OX54 also showed 
good staining but OX19 (CD5) did not give strong staining of inflammatory infiltrates. 
 
Immunostaining of lumbar spinal cord sections at different stages of EAE 
 
The following results were obtained by immunostaining sections of lumbar spinal cord. 
Controls. In two uninoculated control rats we found, as has been described by others 
(Hickey et al. 1985; Vass et al. 1986), that OX6 stained occasional round cells in the 
meninges and around blood vessels. OX42 stained presumptive microglia, identified by 
their dendritic morphology, in the grey and white matter of the spinal cord. W3/25 gave 
weak staining of similar dendritic cells. R73 stained very occasional round cells in the 
meninges. 
Rats before neurological signs of EAE (days 9-12 after inoculation). In 1 rat sampled at 
day 9 and 1 rat sampled at day 10 the appearances were similar to those of controls. 
One rat at day 11 had an increased number of OX6-labelled cells in the meninges and 
one sampled at day 12 had increased numbers of both OX6+ and OX34+ cells in the 
meningeal region. 
Rats with neurological signs of EAE (days 11-16 after inoculation). Three rats studied on 
the day of onset of neurological signs (at day 11 after inoculation) had an inflammatory 
infiltrate, which stained with antibodies to T cells and macrophages and to Ia, in the 
meningeal and perivascular regions. No la staining of parenchymal cells was observed. 
Sections were taken from 6 rats with established neurological signs of EAE (at days 
13-16 after inoculation). Of' these, 4 rats had tail weakness only and 2 had hindlimb and 
tail weakness. In all rats the staining pattern was similar. The T cell markers R73 and 
OX34 labelled large numbers of cells in the meningeal and subpial regions, in the white 
matter of the spinal cord and to a lesser extent in the grey matter. Many cells were 
located around blood vessels (Fig. 1). Cells la-belled with T lymphocyte markers were 
also present in the peripheral nervous system in the nerve roots. Cells labelled by the B 
cell marker, OX33, were not observed. There was strong staining of round cells in the 
meninges, around blood vessels and in the parenchyma with W3/25. W3/25 also 
labelled dendritic cells in the parenchyma. There was strong staining of round cells in 
perivascular regions, in submeningeal areas and diffusely in the white matter (Fig. 1) 
with the OX22 antibody. Comparison of adjacent sections indicated that cellular 
infiltrates that were labelled with R73 and OX34 also stained positively with W3/25 and 
OX22(CD45RC) (Fig. 2). OX8 stained only a small proportion of the cells. Very few 
 cells were stained with OX39. OX42 labelled round cells in meningeal regions, in the 
parenchyma and around blood vessels. This antibody also labelled resident dendritic 
cells throughout the spinal cord (Fig. 1). Some regions that were labelled with OX42 
did not label with OX22 and vice versa (Fig. 3), indicating that OX22+ cells that were 
not macrophages were present. 
Strong staining was obtained with the OX6 antibody (Fig. 4). OX6+ round cells were 
prominent in perivascular and meningeal regions and also were seen in the white matter 
and to some extent, grey matter. OX6+ cells with dendritic morphology were also 
observed in white and grey matter in a similar distribution to OX42+ dendritic cells. 
 
 
 
Fig. 2. Sections from the lumbar spinal cord of a rat with neurological signs of EAE. All sections are from 
the same block of tissue. A: labelled with W3/25. Positively stained round cells (arrow) are seen beneath the 
meninges. Some positively stained dendritic cells (arrowhead) are also seen. B: labelled with R73. Positively 
stained round cells are seen in the submeningeal region. C: labelled with OX22. Positively stained round 
cells are seen in a similar distribution to the cells in (B). These 3 sections show that cells in the same region 
are labelled with W3/25 (CD4), R73 (a/3 T cell receptor) and OX22 (CD45RC). Bar = 25 µm. 
 
 
Rats studied after clinical recovery (days 15-33 after inoculation). Four rats were 
studied at this stage of disease. In all these rats the T cell infiltrate was reduced to a few 
small perivascular clusters. OX42+ round cells were largely restricted to a perivascular 
distribution. OX42 labelling of dendritic cells in the parenchyma was increased 
compared to normal. Ia antigen was expressed on dendritic cells diffusely throughout 
the grey and white matter in rats studied at days 15, 16, 21 and 33 after inoculation 
(Fig. 4). 
 
 Extraction of cells from spinal cords 
The mean yield of cells from rats on the first day of neurological signs (on days 11-13 
after inoculation) was 1.2 X 106/g spinal cord (n = 6). The mean yield of cells from rats 
with established neurological signs of EAE on days 13 or 14 after inoculation was 4.5 x 
106/ g  spinal cord (n = 16). The extracted cells were immunostained with indirect 
peroxidase labelling and examined on a slide. Many cells labelled with lymphocyte and 
macrophage markers. No cells labelled with anti GFAP, which labels astrocytes. Many 
cells labelled with anti MBP, but there were probably macrophages which had ingested 
myelin and expressed MBP, as macrophage labelling with anti MBP is a marker of 
demyelination (Prineas et al. 1989). 
 
 
 
Fig. 3. Sections from the lumbar spinal cord of the same rat shown in Fig. 2. A: labelled with OX42. 
Perivascular cells (arrowhead) are densely labelled with OX42. In the parenchyma, the labelled cells have 
dendritic morphology. B: labelled with OX22. Few cells around the blood vessel are labelled. However, 
round cells labelled with OX22 are scattered through the parenchymal tissue (arrow). These sections show 
cells which are labelled with OX42 but not OX22 and vice versa. Bar = 25 µm. 
 
Flow cytometry 
The results of flow cytometry analysis of cells extracted from the spinal cord of rats with MBP-
EA are shown in Table 1. In rats with established neurological signs of EAE, a mean of 57(SD, 
19)% of cells were W3/25+, a mean of 48(SD, 3)% were OX34+, and a mean of 30(SD, 6)% 
were OX22+. Because CD4 is expressed on macrophages and T lymphocytes, we per-formed 
double labelling to quantity CD4+ T lymphocytes. In the cells extracted from the spinal cord, a 
mean of 83(SD, 23)% of OX34+ cells were also CD4+. Because of the possibility that OX22 
may be expressed on macrophages as well as lymphocytes, we performed double labelling with 
OX22 and macrophage or T cell markers. OX22 labelled a mean of 27(SD, 12)% of OX34+ 
cells and a mean of 47(SD, 32)% of OX42+cells. As shown in Table 1, in cells obtained from 
 rats on the first day of EAE, a mean of 43(SD, 22)% of CD2+ T cells were also OX22% and a 
mean of 90(SD, 36)% of OX42+ cells were OX22+. 
 
 
 
Fig. 4. Sections from the spinal cord of rats at different stages after inoculation with MBP. Each section is 
labelled with the OX6 (Ia) antibody using the indirect peroxidase technique. A: section from a rat with no 
neurological signs at day 11 after inoculation. In this field there is non-specific staining only. Bar = 25 µm. B: 
section from a rat on the first day of neurological signs of EAE. Positively stained cells are present in the 
meningeal and subpial regions. Bar = 100 µm. C: section from a rat on the second day of neurological signs. 
Many positively stained round cells and dendritic cells are present within the parenchyma. Bar = 25 µm. D: 
section from a rat on the first day after clinical recovery from MBP-EAE. Many positively stained cells are 
present throughout the cord. Most have dendritic morphology. Bar = 100 µm. 
 
Discussion 
 
In our immunocytochemical study on tissue from Lewis rats with acute MBP-EAE, we 
obtained the best staining using frozen tissue lightly fixed with acetone/ alcohol. Others have 
 also used fresh unfixed tissue in immunocytochemical studies of EAE (Traugott et al. 1982; 
Hickey et al. 1983; Sobel et al. 1984; Matsumoto and Fujiwara 1987). Using paraformaldehyde 
fixation, Lassmann et al. (1986a,b) were able to demonstrate lymphocytes and la expression in 
EAE. However, aldehyde fixation can reduce the availability of lymphocyte and macrophage 
antigens for immunostaining (Smit et al. 1974; Walker et al. 1984), and we chose to maximize 
the number of antigenic sites available for binding by avoiding aldehyde fixation. 
In an earlier study of MBP-EAE Hickey et al. (1983) found few lymphocytes. We found that 
many of the infiltrating cells were T lymphocytes. This difference is most likely accounted for 
by our usage of newer anti-lymphocyte antibodies, especially R73 (αβ T cells receptor) and 
OX34 (CD2). Our flow cytometric study of cells extracted from the spinal cord of rats with 
established neurological signs of MBP-EAE showed that 48% were CD2+ (T cells or natural 
killer cells) and 24% were OX42+ (macrophages or microglia). The remaining 28% may have 
been OX42- microglia. B cells were not detected in the present study using OX33 as a label. 
Hickey et al. (1983) found that in MBP-EAE a small percentage of Ia+ cells had surface 
immunoglobulin and were thus typical of B cells. Small numbers of meningeal B cells have 
been described in acute EAE induced in guinea pigs by inoculation with bovine white matter 
(Traugott et al. 1982) or in mice by inoculation with isogeneic spinal cord (Traugott et al. 
1985). 
Our immunocytochemical studies showed that a high proportion of the infiltrating cells were 
CD4+ while only a small proportion were CD8+. With flow cytometry we confirmed that in 
established EAE, a mean of 57(SD, 19)% of the cells were labelled with CD4. Comparison of 
sections from the same region of inflammation suggested that many of these CD4+ cells were 
CD2+ and expressed the αβ T cell receptor and were therefore CD4+ T cells. With flow 
cytometry, we found that the percentage of CD2+ lymphocytes was greater than the percentage 
bearing the αβ T cell receptor. CD2+ lymphocytes which do not bear the αβ T cell receptor 
may be γδ T cells or natural killer cells. The presence of CD4+ T cells was confirmed by flow 
cytometry where, in established disease, a mean of 83(SD, 23)% of OX34+ cells were CD4+. 
The CD4-lymphocytes might include CD8+ cells or γδ T cells. As CD4+ lymphocytes can have 
cytotoxic (Sun and Wekerle 1986) or suppressor functions (Karpus and Swanborg 1989) as well 
as providing B cell help and mediating delayed-type hypersensitivity, staining with other 
markers is necessary to characterize these cells further. 
 
TABLE 1 
                     Rats on 1st day of neurological signs  Rats with established neurological signs 
                          (11-13 days after inoculation)           (12-14 days after inoculation) 
    Mean  SD n Mean  SD  n 
Yield 
Cells/g 1.2 X 106                            6                4.5 x 106                                  16 
Percentage labelling with different markersa 
0X34 37 13 6 48 3 4 
R73+ 21 2 3 32 19 3 
OX42+ 16 11 6 24 10 3 
OX22+ 24 14 6 30   6 5 
W3/25 43 6 6 57 19 3 
OX34+OX22+ 16 12 5 13   6 4 
(OX34 + OX22 +)/OX34 + 43 22 6 27 12 4 
R73+OX22+% 8 2.6 3 11 13 3 
(R73 + OX22 + )/ R73 + 39 16 3 29 20 3 
OX34+W3/25+ 34 9 5 41 17 2 
(OX34+W3/25+)/OX34+ 99 15 5 83 23 2 
OX42+OX22+ 12 6 6   9   5 3 
OX42+OX22+OX42+ 90  36 6 47 32 3 
 
a For the single markers, the percentage is that of the total population of cells extracted from the spinal cord. The 
ratios show the percentage of cells labelled with one marker which are also labelled with a second marker. 
 
The OX22 monoclonal antibody binds to CD45RC (Powrie and Mason 1990, 1991) 
and can be used to divide CD4+ T lymphocytes into two subsets (Spickett et al. 1983). Using 
 the OX22 monoclonal antibody we have found that many cells in this model of EAE are 
strongly CD45RC+. The strong staining obtained with OX22 may occur because the leucocyte 
common antigen comprises approximately 10% of the surface of lymphocytes (Thomas and 
Lefrancois, 1988). OX22 labels CD45RC on CD4+ and CD8+ T lymphocytes and on B cells. 
There are no published studies of whether, in the rat, OX22 labels macrophages. As we found 
no B cells and only a small number of CD8+ T lymphocytes in this study, we reasoned that the 
cells labelled with OX22 were CD4+ T lymphocytes or possibly macrophages. With 
immunocytochemistry we found that some regions which were heavily labelled with OX22 
were not labelled with the macrophage marker OX42 and vice versa (Fig. 4). We therefore 
concluded that at least some of the CD45RC+ cells were T lymphocytes. With flow cytometric 
analysis of the extracted cells we found that a mean of 27(SD, 12)% of CD2+ lymphocytes 
expressed high levels of CD45RC. We also found that a mean of 47(SD, 32)% of OX42+ cells 
expressed high levels of CD45RC thus demonstrating that, in the rat, OX42+ cells 
(macrophages or microglia) also can express CD45RC. 
The CD4+ CD45RC+ T cell subset produces IL-2 and IFN-γ (Mason and Powrie 1990) and in 
this respect resembles the T helper 1 subset of mouse CD4+ T cells, which can mediate delayed-
type hypersensitivity and CD4+ T-cell cytotoxicity (Erb et al. 1990). This subset also includes 
naive or unprimed T lymphocytes (Powrie and Mason 1988). In EAE, CD45RC+CD4+ T cells 
might be effector cells, as delayed-type hypersensitivity is commonly thought to occur in this 
disease. However, Sedgwick et al. (1987) have suggested a role for cytotoxic CD4+ T cells in 
EAE. Our morphological studies suggest there may be apoptosis of oligodendrocytes in the 
nervous system in MBP-EAE (Pender et al. 1991). This suggests a possible role for CD4+ 
cytotoxic T cells, as apoptosis is the mechanism of cytotoxic T-cell-induced target cell death 
(Pender et al. 1991). Using other methods, Hayosh et al. (1989) provided evidence that the 
effector cells in EAE are CD45RC+ and Powrie and Mason (1990) have shown that autoreactive 
T cells are included in the CD4+OX45RC+ T cell population. However, Day and Mason (1990) 
found that an encephalitogenic T cell line was CD45RC−. We found that the majority of the 
lymphocytes in the spinal cord were CD45RC−. CD45RC is lost from CD4+ T cells after 
activation by exposure to antigen (Powrie and Mason, 1989). The CD45RC− subset contains 
cells responsible for B cell help and cells able to regulate the CD45RC+ population (Powrie and 
Mason 1990) and also cells which are responsible for memory (Fowell et al. 1991). Jensen et al 
(1989) found that the percentage of CD4+CD45RC+ cells was reduced in spinal cord 
compared to peripheral blood in rats with EAE induced by inoculation with guinea pig 
spinal cord. Clearly, further studies are required to determine whether the lack of 
expression of CD45RC on the majority of spinal cord T lymphocytes reflects activation 
of the cells or a functional capacity similar to mouse T helper 2 cells. Studies of 
cytokine production will help to answer this question. 
In the present study, only a small proportion of the infiltrating T cells were activated 
as indicated by staining with the OX39 antibody to IL-2R. Sedgwick et al. (1987) 
demonstrated that only a small proportion of lymphocytes were IL-2R+ in the spinal 
cord of rats with passively transferred MBP-EAE and suggested that this was because 
only CNS-specific T cells were likely to be activated in the CNS. It has been shown that 
only a small proportion of the cells in the CNS in EAE are likely to be MBP-specific 
(Cohen et al. 1987). Other possible explanations for the infrequency of IL-2R+ cells in 
the CNS are that IL-2R may be ex-pressed for only a short period after T cell receptor 
stimulation (Smith 1988) or that, as we have recently suggested, MBP-specific T cells 
may be dying by apoptosis in the spinal cord and thereby being deleted (Pender et al. 
1991, 1992). 
We observed that Ia antigen, which is also expressed on activated T cells, was 
prominently expressed on infiltrating T cells and macrophages, and on resident 
dendritic cells (microglia) during established clinical disease. Polman et al. (1986) 
found la+ lymphocytes in the spinal cord of rats with EAE induced by inoculation with 
spinal cord tissue. Lyman et al. (1989) identified la+ lymphocytes in cells extracted 
from the spinal cord of rats with MBP-EAE. We found that the Ia expression on 
 dendritic cells persisted after clinical recovery, as observed by Matsumoto et al. (1986) 
and Konno et al. (1989) in EAE induced in the Lewis rat by inoculation with brain or 
spinal cord homogenate. Some of the increased Ia expression may be due to increased 
expression of Ia antigen on individual cells. However, there may also be proliferation of 
microglia in inflammatory CNS diseases (Sedgwick et al. 1991; Ohmori et al. 1992). As 
Ia expression is necessary for antigen presentation to CD4+ T cells, it might be expected 
that Ia expression within the nervous system would enhance the development of EAE. 
However, the prominence of Ia expression on dendritic cells after clinical recovery 
raises the possibility that Ia expression has a role in the termination of the immune 
attack. Voorthuis et al. (1990) found that the intraventricular administration of IFN-γ, 
which increases Ia expression in the CNS, sup-presses EAE, and Konno et al. (1989) 
suggested that Ia expression may also assist with repair processes. Thus la expression in 
the later stages of EAE may be part of a protective response. Ia expression on non-
professional antigen presenting cells may provide T cell receptor stimulation without 
providing the second signal, thus leading to anergy (Ohmori et al. 1992) or apoptosis of 
T cells (Pender et al., 1992). 
In conclusion, this combined immunocytochemical and flow cytometry study of acute 
MBP-EAE found that CD45RC+ cells were present in the inflammatory infiltrate but the 
majority of T cells were CD45RC−. It also showed widespread microglial Ia expression 
which persists after clinical recovery. 
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